Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05489237
Title A First-in-human (FIH) Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (GIST) [Study ID: StrateGIST 1]
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors IDRx, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ESP | DEU | BEL

Additional content available in CKB BOOST